Basel Medical Group Ltd (NASDAQ:BMGL – Get Free Report) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totaling 24,576 shares, a decline of 77.7% from the April 30th total of 110,046 shares. Based on an average trading volume of 31,239 shares, the days-to-cover ratio is presently 0.8 days. Currently, 0.1% of the company’s stock are short sold.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings downgraded Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.
View Our Latest Stock Analysis on Basel Medical Group
Basel Medical Group Trading Up 1.6%
Institutional Investors Weigh In On Basel Medical Group
Several hedge funds have recently added to or reduced their stakes in the stock. Marex Group plc purchased a new position in shares of Basel Medical Group in the second quarter worth $25,000. Vanguard Personalized Indexing Management LLC purchased a new position in shares of Basel Medical Group in the third quarter worth $40,000. Virtu Financial LLC raised its stake in shares of Basel Medical Group by 108.8% in the third quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after purchasing an additional 17,608 shares during the last quarter. Finally, Citadel Advisors LLC purchased a new position in shares of Basel Medical Group in the third quarter worth $169,000.
Basel Medical Group Company Profile
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.
See Also
- Five stocks we like better than Basel Medical Group
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
